84 results on '"Leipsic, Jonathon"'
Search Results
2. Redo Transcatheter Aortic Valve Implantation with the ALLEGRA Transcatheter Heart Valve: Insights from Bench Testing
- Author
-
Akodad, Mariama, Kütting, Maximilian, Sellers, Stephanie, Kirsten, Alina, Marx, Philipp, Kim, Isabel, Cheung, Anson, Leipsic, Jonathon, Søndergaard, Lars, Toggweiler, Stefan, Wood, David A., Webb, John G., and Sathananthan, Janarthanan
- Published
- 2022
- Full Text
- View/download PDF
3. Artificial Intelligence-Based Diagnosis and Procedural Planning for Aortic Valve Disease
- Author
-
Indraratna, Praveen, Leipsic, Jonathon, Schoepf, U. Joseph, Series Editor, De Cecco, Carlo N., editor, van Assen, Marly, editor, and Leiner, Tim, editor
- Published
- 2022
- Full Text
- View/download PDF
4. Comprehensive Myocardial Assessment by Computed Tomography: Impact on Short-Term Outcomes After Transcatheter Aortic Valve Replacement.
- Author
-
Koike, Hideki, Fukui, Miho, Treibel, Thomas, Stanberry, Larissa I., Cheng, Victor Y., Enriquez-Sarano, Maurice, Schmidt, Stephanie, Schelbert, Erik B., Wang, Cheng, Okada, Atsushi, Phichaphop, Asa, Sorajja, Paul, Bapat, Vinayak N., Leipsic, Jonathon, Lesser, John R., and Cavalcante, João L.
- Abstract
Quantification of myocardial changes in severe aortic stenosis (AS) is prognostically important. The potential for comprehensive myocardial assessment pre–transcatheter aortic valve replacement (TAVR) by computed tomography angiography (CTA) is unknown. This study sought to evaluate whether quantification of left ventricular (LV) extracellular volume—a marker of myocardial fibrosis—and global longitudinal strain—a marker of myocardial deformation—at baseline CTA associate with post-TAVR outcomes. Consecutive patients with symptomatic severe AS between January 2021 and June 2022 who underwent pre-TAVR CTA were included. Computed tomography extracellular volume (CT-ECV) was derived from septum tracing after generating the 3-dimensional CT-ECV map. Computed tomography global longitudinal strain (CT-GLS) used semi-automated feature tracking analysis. The clinical endpoint was the composite outcome of all-cause mortality and heart failure hospitalization. Among the 300 patients (80.0 ± 9.4 years of age, 45% female, median Society of Thoracic Surgeons Predicted Risk of Mortality score 2.80%), the left ventricular ejection fraction (LVEF) was 58% ± 12%, the median CT-ECV was 28.5% (IQR: 26.2%-32.1%), and the median CT-GLS was −20.1% (IQR: −23.8% to −16.3%). Over a median follow-up of 16 months (IQR: 12-22 months), 38 deaths and 70 composite outcomes occurred. Multivariable Cox proportional hazards model, accounting for clinical and echocardiographic variables, demonstrated that CT-ECV (HR: 1.09 [95% CI: 1.02-1.16]; P = 0.008) and CT-GLS (HR: 1.07 [95% CI: 1.01-1.13]; P = 0.017) associated with the composite outcome. In combination, elevated CT-ECV and CT-GLS (above median for each) showed a stronger association with the outcome (HR: 7.14 [95% CI: 2.63-19.36]; P < 0.001). Comprehensive myocardial quantification of CT-ECV and CT-GLS associated with post-TAVR outcomes in a contemporary low-risk cohort with mostly preserved LVEF. Whether these imaging biomarkers can be potentially used for the decision making including timing of AS intervention and post-TAVR follow-up will require integration into future clinical trials. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Computed Tomography Imaging for Aortic Valve Disease
- Author
-
Ohana, Mickaël, Shaw, Anthony, Grover, Romi, Mooney, John, Leipsic, Jonathon, Blanke, Philipp, Tamburino, Corrado, editor, Barbanti, Marco, editor, and Capodanno, Davide, editor
- Published
- 2018
- Full Text
- View/download PDF
6. MULTI-MODALITY IMAGING IN AORTIC STENOSIS:AN EACVI CLINICAL CONSENSUS DOCUMENT
- Author
-
Dweck, Marc R, Loganath, Krithika, Bing, Rong, Treibel, Thomas A., McCann, Gerry P, Newby, David E, Leipsic, Jonathon, Fraccaro, Chiara, Paolisso, Pasquale, Cosyns, Bernard, Habib, Gilbert, Cavalcante, João, Donal, Erwan, Lancellotti, Patrizio, Clavel, Marie-Annick, Otto, Catherine M, and Pibarot, Phillipe
- Subjects
Cardiac computed tomography ,Cardiac magnetic resonance ,Echocardiography ,Positron-Emission Tomography ,aortic stenosis - Abstract
In this EACVI clinical scientific update, we will explore the current use of multi-modality imaging in the diagnosis, risk-stratification and follow-up of patients with aortic stenosis, with a particular focus on recent developments and future directions. Echocardiography is and will likely remain the key method of diagnosis and surveillance of aortic stenosis providing detailed assessments of valve haemodynamics and the cardiac remodelling response. CT is already widely used in the planning of transcutaneous aortic valve implantation. We anticipate its increased use as an anatomical adjudicator to clarify disease severity in patients with discordant echocardiographic measurements. CT calcium scoring is currently used for this purpose, however contrast computed tomography techniques are emerging that allow identification of both calcific and fibrotic valve thickening. Additionally, improved assessments of myocardial decompensation with echocardiography, cardiac magnetic resonance and computed tomography will become more commonplace in our routine assessment of aortic stenosis. Underpinning all of this will be widespread application of artificial intelligence. In combination we believe this new era of multi-modality imaging in aortic stenosis will improve the diagnosis, follow-up and timing of intervention in aortic stenosis as well as potentially accelerate the development of the novel pharmacological treatments required for this disease.
- Published
- 2023
7. Multimodality assessment of high- vs. low-gradient aortic stenosis using echocardiography and cardiac CT.
- Author
-
Zeb, Irfan, Uqaily, Raafay, Gonuguntla, Karthik, Ludhwani, Dipesh, Abdelhaleem, Ahmed, Leipsic, Jonathon, Hahn, Rebecca T., Pibarot, Philippe, Sankaramangalam, Kesavan, Kuzhandai, Dhivya, Sattar, Yasar, Raina, Sameer, Sudarshan, Balla, Kawsara, Mohammad, Hamirani, Yasmin, and Daggubati, Ramesh
- Abstract
Aortic valve area (AVA) using CT-LVOT area (AVA CT-LVOT) <1.2 cm
2 has been shown comparable to echocardiography AVA of <1.0 cm2 for severe aortic stenosis (AS). Current study evaluates how AS diagnosis will be affected when we substitute CT-LVOT with echo derived LVOT. We retrospectively studied 367 patients who underwent cardiac CTA and echocardiogram for assessment of high- and low-gradient AS (HG-AS and LG-AS). AVA CT-LVOT was derived from CT-LVOT area and echo doppler data. Three AVA CT-LVOT categories were created (<1.0, 1.0–1.2 and > 1.2 cm2 ). Outcomes were defined as composite of all-cause mortality and/or valve intervention. Median echocardiographic profiles were consistent with severe AS across three AVA CT-LVOT categories for HG-AS. HG-AS patients with AVA CT-LVOT >1.2 cm2 had larger median CT-LVOT area (5.06 cm2 ) and AVC (2917AU). Among LG-AS with AVA CT-LVOT ≤1.2 cm2 , 57% met echo criteria for low-flow LG-AS and 63% met criteria for severe AS using aortic valve calcium (AVC). Additionally, 45% with AVA CT-LVOT >1.2 cm2 had larger median CT-LVOT area (5.43 cm2 ) and AVC (2389AU). Patients with AVA CT-LVOT >1.2 cm2 and high AVC had large body surface area and were mostly characterized as severe with indexed AVA and AVC. Stroke volume index using CT-LVOT reclassified 70% of low-flow, LG-AS as normal flow, LG-AS. Composite outcomes were higher among patients with AVA CT-LVOT ≤1.2 cm2 (p < 0.01), however, with no superior net reclassification improvement compared to AVA echo <1.0 cm2 . AVA CT-LVOT ≤1.2 cm2 is a reasonable CT criterion for severe AS. Large LVOT with elevated AVC identified a severe AS phenotype despite an AVA CT-LVOT >1.2 cm2 , best characterized by indexed AVA and AVC. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
8. Multi-modality imaging in aortic stenosis: an EACVI clinical consensus document.
- Author
-
Dweck, Marc R, Loganath, Krithika, Bing, Rong, Treibel, Thomas A, McCann, Gerry P, Newby, David E, Leipsic, Jonathon, Fraccaro, Chiara, Paolisso, Pasquale, Cosyns, Bernard, Habib, Gilbert, Cavalcante, João, Donal, Erwan, Lancellotti, Patrizio, Clavel, Marie-Annick, Otto, Catherine M, and Pibarot, Phillipe
- Subjects
PATIENT aftercare ,CONSENSUS (Social sciences) ,ECHOCARDIOGRAPHY ,PUBLIC health surveillance ,HEART valve prosthesis implantation ,AORTIC stenosis ,CONTRAST media ,MAGNETIC resonance imaging ,ARTIFICIAL intelligence ,DIAGNOSTIC imaging ,RISK assessment ,SEVERITY of illness index ,POSITRON emission tomography ,HEMODYNAMICS ,COMPUTED tomography ,DISEASE risk factors - Abstract
In this EACVI clinical scientific update, we will explore the current use of multi-modality imaging in the diagnosis, risk stratification, and follow-up of patients with aortic stenosis, with a particular focus on recent developments and future directions. Echocardiography is and will likely remain the key method of diagnosis and surveillance of aortic stenosis providing detailed assessments of valve haemodynamics and the cardiac remodelling response. Computed tomography (CT) is already widely used in the planning of transcutaneous aortic valve implantation. We anticipate its increased use as an anatomical adjudicator to clarify disease severity in patients with discordant echocardiographic measurements. CT calcium scoring is currently used for this purpose; however, contrast CT techniques are emerging that allow identification of both calcific and fibrotic valve thickening. Additionally, improved assessments of myocardial decompensation with echocardiography, cardiac magnetic resonance, and CT will become more commonplace in our routine assessment of aortic stenosis. Underpinning all of this will be widespread application of artificial intelligence. In combination, we believe this new era of multi-modality imaging in aortic stenosis will improve the diagnosis, follow-up, and timing of intervention in aortic stenosis as well as potentially accelerate the development of the novel pharmacological treatments required for this disease. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Course of early subclinical leaflet thrombosis after transcatheter aortic valve implantation with or without oral anticoagulation
- Author
-
Ruile, Philipp, Jander, Nikolaus, Blanke, Philipp, Schoechlin, Simon, Reinöhl, Jochen, Gick, Michael, Rothe, Juergen, Langer, Mathias, Leipsic, Jonathon, Buettner, Heinz-Joachim, Neumann, Franz-Josef, and Pache, Gregor
- Published
- 2017
- Full Text
- View/download PDF
10. Role of MDCT Imaging in Planning Mitral Valve Intervention
- Author
-
Grover, Rominder, Ohana, Mickael, Arepalli, Chesnal Dey, Sellers, Stephanie L., Mooney, John, Kueh, Shaw-Hua, Kim, Ung, Blanke, Philipp, and Leipsic, Jonathon A.
- Published
- 2018
- Full Text
- View/download PDF
11. Transcatheter Aortic Valve Replacement Planning with Cardiac CT: Protocols and Practical Tips
- Author
-
Soon, Jeanette, Naoum, Christopher, Blanke, Philipp, and Leipsic, Jonathon
- Published
- 2016
- Full Text
- View/download PDF
12. Clinical and Echocardiographic Characteristics of Flow-Based Classification Following Balloon-Expandable Transcatheter Heart Valve in PARTNER Trials.
- Author
-
Akinmolayemi, Oludamilola, Ozdemir, Denizhan, Pibarot, Philippe, Zhao, Yanglu, Leipsic, Jonathon, Douglas, Pamela S., Jaber, Wael A., Weissman, Neil J., Blanke, Philipp, and Hahn, Rebecca T.
- Abstract
Current expected normal echocardiographic measures of transcatheter heart valve (THV) function were derived from pooled cohorts of the randomized trials; however, THV function by flow state before or following transcatheter aortic valve replacement (TAVR) has not been previously reported. This study sought to assess the expected normal echocardiographic hemodynamics for the balloon-expandable THV grouped by stroke volume index (SVI). Patients with severe aortic stenosis enrolled in PARTNER (Placement of Aortic Transcatheter Valves) 1 (high/extreme surgical risk), PARTNER 2 (intermediate surgical risk), or PARTNER 3 (low surgical risk) trials with complete core laboratory echocardiography were included. Patients were grouped by low-flow (SVI LOW <35 mL/m
2 ) and normal-flow (SVI NORMAL ≥35 mL/m2 ). Mean gradient, effective orifice area (EOA), and Doppler velocity index (DVI) were collected at baseline and at 30 days post-TAVR. Prosthesis-patient mismatch (PPM) was both calculated and predicted from normative data, using defined criteria. In the entire population (N = 4,991), mean age was 81.8 years, 58% of patients were male, and 42% had low flow. Compared with patients with baseline SVI NORMAL , those with SVI LOW were more likely to be male; have more comorbidities; and lower left ventricular ejection fraction, mean gradient, and EOA. Post-TAVR, SVI LOW increased to SVI NORMAL in 17.3% and SVI NORMAL decreased to SVI LOW in 12.3% of patients. Using baseline SVI, follow-up EOA, mean gradient, and DVI for patients with SVI LOW tended to be lower than for patients with SVI NORMAL. Using the post-TAVR SVI, follow-up EOA, mean gradient, and DVI were significantly lower for patients with SVI LOW than for those with SVI NORMAL (P < 0.001 for all). The incidence of calculated, but not predicted, severe PPM was higher in patients with low flow than it was in patients with normal flow, suggesting pseudo-PPM in the presence of low flow. This study demonstrates that flow affects THV hemodynamics and both baseline and follow-up SVI should be considered when predicting THV hemodynamics prior to TAVR, as well as assessing valve function following valve implantation. [Display omitted] [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
13. Computed tomography imaging for subclinical leaflet thrombosis following surgical and transcatheter aortic valve replacement.
- Author
-
Rashid, Hashrul N., Rajani, Ronak, Leipsic, Jonathon, Maurovitch-Horvat, Pál, Patterson, Tiffany, Redwood, Simon, Lee, Jack, Hurrell, Harriet, Nicholls, Stephen J., Nasis, Arthur, Seneviratne, Sujith, Cameron, James D., Prendergast, Bernard, and Gooley, Robert P.
- Abstract
Subclinical leaflet thrombosis (LT) may occur following surgical and transcatheter aortic valve replacement. Computed tomography (CT) has become an established imaging modality to diagnose subclinical LT following bioprosthetic aortic valve replacement. Even so, there is a limited (but growing) experience in utilizing CT imaging for this indication. This review emphasizes a systematic approach to acquiring and analysing CT imaging for subclinical LT, highlighting evidence surrounding clinical sequelae of subclinical LT and anti-thrombotic implications following diagnosis. Graphical Abstract [Display omitted] Caption: Computed tomography (CT) is an established imaging modality to diagnose subclinical leaflet thrombosis following transcatheter aortic valve replacement (TAVR). The extent of HALT should be graded according to the degree of leaflet thickening along the curvilinear surface of the leaflet (upper panel); Grade 1 (≤25%), Grade 2 (>25–50%), Grade 3 (>50–75%), and Grade 4 (>75%). Routine CT following TAVR is currently not recommended but should be strongly considered in (lower left panel) patients presenting with cryptogenic stroke or new valvular dysfunction (such as significant stenosis or regurgitation). It is essential to ensure CT images are acquired correctly (lower middle panel) by adjusting the CT tube potential settings to the patient by taking into account patient's size and type of prosthesis, adequate heart rate control (below 70 beats per minute), prospective electrocardiogram (ECG) gated imaging (complete R-R interval) and contrast bolus tracking. The CT images should be analysed (lower right panel) for the presence of hypo-attenuated leaflet thickening (HALT) in diastole. The presence of HALT should prompt an assessment for reduced leaflet motion (RELM) during systole and with four-dimensional volume rendering when available. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
14. The Use of Computed Tomography Prior to TAVR: Prediction and Prevention of Complications and Impact on Outcomes
- Author
-
Berger, Adam and Leipsic, Jonathon
- Published
- 2014
- Full Text
- View/download PDF
15. Annular versus supra-annular sizing for transcatheter aortic valve replacement in bicuspid aortic valve disease
- Author
-
Weir-McCall, Jonathan R, Attinger-Toller, Adrian, Blanke, Philipp, Perlman, Gidon Y, Sellers, Stephanie L, Wood, David, Webb, John G, Leipsic, Jonathon, Weir-McCall, Jonathan [0000-0001-5842-842X], and Apollo - University of Cambridge Repository
- Subjects
Male ,Computer tomography ,Bicuspid aortic valve ,Computed Tomography Angiography ,Heart Valve Diseases ,Coronary Angiography ,Prosthesis Design ,Severity of Illness Index ,Transcatheter Aortic Valve Replacement ,Bicuspid Aortic Valve Disease ,Predictive Value of Tests ,Multidetector Computed Tomography ,Humans ,Aged ,Retrospective Studies ,Aged, 80 and over ,Aortic stenosis ,Aortic Valve Stenosis ,Tavr ,Middle Aged ,Valvular disease ,Treatment Outcome ,Echocardiography ,Aortic Valve ,Heart Valve Prosthesis ,Female - Abstract
BACKGROUND: CT measurement of supra-annular area (SA) has been proposed as an alternative to annular area (AA) for sizing of trancatheter valves in biscuspid aortic valves (BAV). This study examines the reproducibility of SA and AA measurements and their potential impact on downstream transcatheter heart valve sizing and clinical outcomes. METHODS: 44 consecutive patients (mean age: 73 ± 15 years, 57% male) undergoing CTA with subsequent SAPIEN 3 valve insertion for severe bicuspid aortic stenosis (AS) were included. AA was measured at the basal ring. SA was measured by generating a circle defined by the intercommisural distance. AA and SA were measured by 2 independent observers. Baseline characteristics, TAVR procedural data, and discharge echocardiography data were collected. RESULTS: The SA was significantly larger than the AA (562 ± 146mm2 vs. 518 ± 112mm2,p = 0.013). Interobserver agreement was high using both techniques (ICC AA = 0.98,p < 0.001; SA = 0.80,p < 0.001), but with narrower limits of agreement with AA measurements (mean difference (limits of agreement): AA = -3mm2 (22; 19), SA = -16mm2 (-92; 76)). AA-based device sizing demonstrated substantial agreement with final valve inserted (κ = 0.72,p < 0.001), while SA demonstrated fair agreement (κ = 0.40,p < 0.001). There was no difference in post TAVR gradients, paravalvular leakage or valve success between patients with concordant sizing between AA and SA, and those in whom SA would have suggested an alternate valve size. CONCLUSIONS: Supra-annular sizing is less reproducible than annular sizing, with no difference in procedural complication rates in patients in whom supra-annular sizing would have altered the device size used. These results suggest no role for supra-annular sizing in current clinical practice.
- Published
- 2020
- Full Text
- View/download PDF
16. The PARTNER 3 Bicuspid Registry for Transcatheter Aortic Valve Replacement in Low-Surgical-Risk Patients.
- Author
-
Williams, Mathew R., Jilaihawi, Hasan, Makkar, Raj, O'Neill, William W., Guyton, Robert, Malaisrie, S. Chris, Brown, David L., Blanke, Philipp, Leipsic, Jonathon A., Pibarot, Philippe, Hahn, Rebecca T., Leon, Martin B., Cohen, David J., Bax, Jeroen J., Kodali, Susheel K., Mack, Michael J., Lu, Michael, and Webb, John G.
- Abstract
The study compared 1-year outcomes between transcatheter aortic valve replacement (TAVR) patients with bicuspid aortic valve (BAV) morphology and clinically similar patients having tricuspid aortic valve (TAV) morphology. There are limited prospective data on TAVR using the SAPIEN 3 device in low-surgical-risk patients with severe, symptomatic aortic stenosis and bicuspid anatomy. Low-risk, severe aortic stenosis patients with BAV were candidates for the PARTNER 3 (Placement of Aortic Transcatheter Valves 3) (P3) bicuspid registry or the P3 bicuspid continued access protocol. Patients treated in these registries were pooled and propensity score matched to TAV patients from the P3 randomized TAVR trial. Outcomes were compared between groups. The primary endpoint was the 1-year composite rate of death, stroke, and cardiovascular rehospitalization. Of 320 total submitted BAV patients, 169 (53%) were treated, and most were Sievers type 1. The remaining 151 patients were excluded caused by anatomic or clinical criteria. Propensity score matching with the P3 TAVR cohort (496 patients) yielded 148 pairs. There were no differences in baseline clinical characteristics; however, BAV patients had larger annuli and they experienced longer procedure duration. There was no difference in the primary endpoint between BAV and TAV (10.9% vs 10.2%; P = 0.80) or in the rates of the individual components (death: 0.7% vs 1.4%; P = 0.58; stroke: 2.1% vs 2.0%; P = 0.99; cardiovascular rehospitalization: 9.6% vs 9.5%; P = 0.96). Among highly select bicuspid aortic stenosis low-surgical-risk patients without extensive raphe or subannular calcification, TAVR with the SAPIEN 3 valve demonstrated similar outcomes to a matched cohort of patients with tricuspid aortic stenosis. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
17. Balloon-Expandable Valve for Treatment of Evolut Valve Failure: Implications on Neoskirt Height and Leaflet Overhang.
- Author
-
Akodad, Mariama, Sellers, Stephanie, Landes, Uri, Meier, David, Tang, Gilbert H.L., Gada, Hemal, Rogers, Toby, Caskey, Michael, Rutkin, Bruce, Puri, Rishi, Rovin, Joshua, Leipsic, Jonathon, Sondergaard, Lars, Grubb, Kendra J., Gleason, Patrick, Garde, Kshitija, Tadros, Hatem, Teodoru, Sebastian, Wood, David A., and Webb, John G.
- Abstract
This study sought to determine the degree of Evolut (Medtronic) leaflet pinning, diameter expansion, leaflet overhang, and performance at different implant depths of the balloon-expandable Sapien 3 (S3, Edwards Lifesciences LLC) transcatheter heart valve (THV) within the Evolut THV. Preservation of coronary access and flow is a major factor when considering the treatment of failed Evolut THVs. An in vitro study was performed with 20-, 23-, 26-, and 29-mm S3 THVs deployed within 23-, 26-, 29-, and 34-mm Evolut R THVs, respectively. The S3 outflow was positioned at various depths at node 4, 5, and 6 of the Evolut R. Neoskirt height, leaflet overhang, performance, and Evolut R valve housing diameter expansion were assessed under physiological conditions as per ISO 5840-3 standard. The neoskirt height for the Evolut R was shorter when the S3 outflow was positioned at node 4 compared with node 6 (node 4 height for 23 mm = 16.3 mm, 26 mm = 17.1 mm, 29 mm = 18.3 mm, and 34 mm = 19.9 mm vs node 6 height for 23 mm = 23.9 mm, 26 mm = 23.4 mm, 29 mm = 24.7 mm, and 34 mm = 27 mm Evolut R). All configurations exhibited acceptable hydrodynamic performance irrespective of the degree of leaflet overhang, except the 29-mm S3 implanted in 34-mm Evolut R at node 4 (regurgitant fraction >20%). The valve housing radius of the index Evolut R increased when the S3 was implanted, with the increase ranging from 0 to 2.5 mm. Placement of the S3 at a lower implant position within an index Evolut R reduces the neoskirt height with no significant compromise to S3 valve function despite a higher degree of leaflet overhang. Low S3 implantation may facilitate future coronary access after redo transcatheter aortic valve replacement. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. Impact of Annular Oversizing on Paravalvular Regurgitation and Valve Hemodynamics: New Insights From PARTNER 3.
- Author
-
Ihdayhid, Abdul Rahman, Leipsic, Jonathon, Hahn, Rebecca T., Pibarot, Philippe, Thourani, Vinod, Makkar, Raj, Kodali, Susheel, Russo, Mark, Kapadia, Samir, Chen, Yanjun, Mack, Michael, Webb, John, Bax, Jeroen, Leon, Martin B., and Blanke, Philipp
- Abstract
This study sought to investigate the impact of computed tomography (CT)–based area and perimeter oversizing on the incidence of paravalvular regurgitation (PVR) and valve hemodynamics in patients treated with the SAPIEN 3 transcatheter heart valve (THV). The incremental value of considering annular perimeter or left ventricular outflow tract measurements and the impact of THV oversizing on valve hemodynamics are not well defined. The PARTNER 3 (Placement of Aortic Transcatheter Valves 3) trial included 495 low-surgical-risk patients with severe aortic stenosis who underwent THV implantation. THV sizing was based on annular area assessed by CT. Area- and perimeter-based oversizing was determined using systolic annular CT dimensions and nominal dimensions of the implanted THV. PVR, effective orifice area, and mean gradient were assessed on 30-day transthoracic echocardiography. Of 485 patients with available CT and echocardiography data, mean oversizing was 7.9 ± 8.7% for the annulus area and 2.1 ± 4.1% for the perimeter. A very low incidence of ≥moderate PVR (0.6%) was observed, including patients with minimal annular oversizing. Incidence of ≥mild PVR and need for procedural post-dilatation were inversely related to the degree of oversizing. For patients with annular dimensions suitable for 2 THV sizes, the larger THV with both area and perimeter oversizing was associated with the lowest incidence of ≥mild PVR (12.0% vs 43.4%; P < 0.0001). Left ventricular outflow tract area oversizing was not associated with PVR. THV prosthesis size, rather than degree of oversizing, had greatest impact on effective orifice area and mean gradient. In low-surgical-risk patients, a low incidence of ≥moderate PVR was observed, including patients with minimal THV oversizing. The degree of prosthesis oversizing had the greatest impact on reducing mild PVR and incidence of post-dilatation, without impacting valve hemodynamics. In selected patients with annular dimensions in between 2 valve sizes, the larger THV device oversized to both the annular area and perimeter reduced PVR and optimized THV hemodynamics. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
19. Prosthesis-Patient Mismatch After Aortic Valve Replacement in the PARTNER 2 Trial and Registry.
- Author
-
Ternacle, Julien, Pibarot, Philippe, Herrmann, Howard C., Kodali, Susheel, Leipsic, Jonathon, Blanke, Philipp, Jaber, Wael, Mack, Michael J., Clavel, Marie-Annick, Salaun, Erwan, Guzzetti, Ezequiel, Annabi, Mohamed-Salah, Bernier, Mathieu, Beaudoin, Jonathan, Khalique, Omar K., Weissman, Neil J., Douglas, Pamela, Bax, Jeroen, Dahou, Abdellaziz, and Xu, Ke
- Abstract
This study aimed to compare incidence and impact of measured prosthesis-patient mismatch (PPM M) versus predicted PPM (PPM P) after surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR). TAVR studies have used measured effective orifice area indexed (EOAi) to body surface area (BSA) to define PPM, but most SAVR series have used predicted EOAi. This difference may contribute to discrepancies in incidence and outcomes of PPM between series. The study analyzed SAVR patients from the PARTNER (Placement of Aortic Transcatheter Valves) 2A trial and TAVR patients from the PARTNER 2 SAPIEN 3 Intermediate Risk registry. PPM was classified as moderate if EOAi ≤0.85 cm
2 /m2 (≤0.70 if obese: body mass index ≥30 kg/m2 ) and severe if EOAi ≤0.65 cm2 /m2 (≤0.55 if obese). PPM M was determined by the core lab–measured EOAi on 30-day echocardiogram. PPM P was determined by 2 methods: 1) using normal EOA reference values previously reported for each valve model and size (PPM P1 ; n = 929 SAVR, 1,069 TAVR) indexed to BSA; and 2) using normal reference EOA predicted from aortic annulus size measured by computed tomography (PPM P2 ; n = 864 TAVR only) indexed to BSA. Primary endpoint was the composite of 5-year all-cause death and rehospitalization. The incidence of moderate and severe PPM P was much lower than PPM M in both SAVR (PPM P1 : 28.4% and 1.2% vs. PPM M : 31.0% and 23.6%) and TAVR (PPM P1 : 21.0% and 0.1% and PPM P2 : 17.0% and 0% vs. PPM M : 27.9% and 5.7%). The incidence of severe PPM M and severe PPM P1 was lower in TAVR versus SAVR (P < 0.001). The presence of PPM by any method was associated with higher transprosthetic gradient. Severe PPM P1 was independently associated with events in SAVR after adjustment for sex and Society of Thoracic Surgeons score (hazard ratio: 3.18;95% CI: 1.69-5.96; P < 0.001), whereas no association was observed between PPM by any method and outcomes in TAVR. EOAi measured by echocardiography results in a higher incidence of PPM following SAVR or TAVR than PPM based on predicted EOAi. Severe PPM P is rare (<1.5%), but is associated with increased all-cause death and rehospitalization after SAVR, whereas it is absent following TAVR. [Display omitted] [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
20. Personalized intervention cardiology with transcatheter aortic valve replacement made possible with a non-invasive monitoring and diagnostic framework.
- Author
-
Khodaei, Seyedvahid, Henstock, Alison, Sadeghi, Reza, Sellers, Stephanie, Blanke, Philipp, Leipsic, Jonathon, Emadi, Ali, and Keshavarz-Motamed, Zahra
- Subjects
HEART valve prosthesis implantation ,AORTIC stenosis ,CARDIOVASCULAR diseases ,BLOOD flow ,HEART function tests - Abstract
One of the most common acute and chronic cardiovascular disease conditions is aortic stenosis, a disease in which the aortic valve is damaged and can no longer function properly. Moreover, aortic stenosis commonly exists in combination with other conditions causing so many patients suffer from the most general and fundamentally challenging condition: complex valvular, ventricular and vascular disease (C3VD). Transcatheter aortic valve replacement (TAVR) is a new less invasive intervention and is a growing alternative for patients with aortic stenosis. Although blood flow quantification is critical for accurate and early diagnosis of C3VD in both pre and post-TAVR, proper diagnostic methods are still lacking because the fluid-dynamics methods that can be used as engines of new diagnostic tools are not well developed yet. Despite remarkable advances in medical imaging, imaging on its own is not enough to quantify the blood flow effectively. Moreover, understanding of C3VD in both pre and post-TAVR and its progression has been hindered by the absence of a proper non-invasive tool for the assessment of the cardiovascular function. To enable the development of new non-invasive diagnostic methods, we developed an innovative image-based patient-specific computational fluid dynamics framework for patients with C3VD who undergo TAVR to quantify metrics of: (1) global circulatory function; (2) global cardiac function as well as (3) local cardiac fluid dynamics. This framework is based on an innovative non-invasive Doppler-based patient-specific lumped-parameter algorithm and a 3-D strongly-coupled fluid-solid interaction. We validated the framework against clinical cardiac catheterization and Doppler echocardiographic measurements and demonstrated its diagnostic utility by providing novel analyses and interpretations of clinical data in eleven C3VD patients in pre and post-TAVR status. Our findings position this framework as a promising new non-invasive diagnostic tool that can provide blood flow metrics while posing no risk to the patient. The diagnostic information, that the framework can provide, is vitally needed to improve clinical outcomes, to assess patient risk and to plan treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
21. Multimodality imaging in valvular heart disease: how to use state-of-the-art technology in daily practice.
- Author
-
Reid, Anna, Blanke, Philipp, Bax, Jeroen J, and Leipsic, Jonathon
- Subjects
HEART valve diseases ,ECHOCARDIOGRAPHY ,CARDIAC imaging ,VASCULAR diseases ,HEART diseases - Abstract
Our understanding of the complexities of valvular heart disease (VHD) has evolved in recent years, primarily because of the increased use of multimodality imaging (MMI). Whilst echocardiography remains the primary imaging technique, the contemporary evaluation of patients with VHD requires comprehensive analysis of the mechanism of valvular dysfunction, accurate quantification of severity, and active exclusion extravalvular consequences. Furthermore, advances in surgical and percutaneous therapies have driven the need for meticulous multimodality imaging to aid in patient and procedural selection. Fundamental decision-making regarding whom, when, and how to treat patients with VHD has become more complex. There has been rapid technological advancement in MMI; many techniques are now available in routine clinical practice, and their integration into has the potential to truly individualize management strategies. This review provides an overview of the current evidence for the use of MMI in VHD, and how various techniques within each modality can be used practically to answer clinical conundrums. Open in new tab Download slide Open in new tab Download slide [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
22. Annular versus supra-annular sizing for transcatheter aortic valve replacement in bicuspid aortic valve disease.
- Author
-
Weir-McCall, Jonathan R., Attinger-Toller, Adrian, Blanke, Philipp, Perlman, Gidon Y., Sellers, Stephanie L., Wood, David, Webb, John G., and Leipsic, Jonathon
- Abstract
CT measurement of supra-annular area (SA) has been proposed as an alternative to annular area (AA) for sizing of trancatheter valves in biscuspid aortic valves (BAV). This study examines the reproducibility of SA and AA measurements and their potential impact on downstream transcatheter heart valve sizing and clinical outcomes. 44 consecutive patients (mean age: 73 ± 15 years, 57% male) undergoing CTA with subsequent SAPIEN 3 valve insertion for severe bicuspid aortic stenosis (AS) were included. AA was measured at the basal ring. SA was measured by generating a circle defined by the intercommisural distance. AA and SA were measured by 2 independent observers. Baseline characteristics, TAVR procedural data, and discharge echocardiography data were collected. The SA was significantly larger than the AA (562 ± 146mm2 vs. 518 ± 112mm2,p = 0.013). Interobserver agreement was high using both techniques (ICC AA = 0.98,p < 0.001; SA = 0.80,p < 0.001), but with narrower limits of agreement with AA measurements (mean difference (limits of agreement): AA = −3mm2 (22; 19), SA = −16mm2 (−92; 76)). AA-based device sizing demonstrated substantial agreement with final valve inserted (κ = 0.72,p < 0.001), while SA demonstrated fair agreement (κ = 0.40,p < 0.001). There was no difference in post TAVR gradients, paravalvular leakage or valve success between patients with concordant sizing between AA and SA, and those in whom SA would have suggested an alternate valve size. Supra-annular sizing is less reproducible than annular sizing, with no difference in procedural complication rates in patients in whom supra-annular sizing would have altered the device size used. These results suggest no role for supra-annular sizing in current clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
23. Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study.
- Author
-
Blanke, Philipp, Leipsic, Jonathon A., Popma, Jeffrey J., Yakubov, Steven J., Deeb, G. Michael, Gada, Hemal, Mumtaz, Mubashir, Ramlawi, Basel, Kleiman, Neal S., Sorajja, Paul, Askew, Judah, Meduri, Christopher U., Kauten, James, Melnitchouk, Serguei, Inglessis, Ignacio, Huang, Jian, Boulware, Michael, Reardon, Michael J., Evolut Low Risk LTI Sub-study Investigators, and Evolut Low Risk LTI Substudy Investigators
- Subjects
- *
AORTIC valve , *AORTIC valve transplantation , *TOMOGRAPHY , *PAMPHLETS , *PERCUTANEOUS balloon valvuloplasty , *HEART valve prosthesis implantation , *PROSTHETICS , *ECHOCARDIOGRAPHY , *RESEARCH , *RESEARCH methodology , *AORTIC stenosis , *EVALUATION research , *MEDICAL cooperation , *COMPARATIVE studies , *RANDOMIZED controlled trials , *PROSTHETIC heart valves , *LONGITUDINAL method ,AORTIC valve surgery - Abstract
Background: Subclinical leaflet thrombosis has been reported after bioprosthetic aortic valve replacement, characterized using 4-dimensional computed tomographic imaging by hypoattenuated leaflet thickening (HALT) and reduced leaflet motion (RLM). The incidence and clinical implications of these findings remain unclear.Objectives: The aim of this study was to determine the frequency, predictors, and hemodynamic and clinical correlates of HALT and RLM after aortic bioprosthetic replacement.Methods: A prospective subset of patients not on oral anticoagulation enrolled in the Evolut Low Risk randomized trial underwent computed tomographic imaging 30 days and 1 year after transcatheter aortic valve replacement (TAVR) or surgery. The primary endpoint was the frequency of HALT at 30 days and 1 year, analyzed by an independent core laboratory using standardized definitions. Secondary endpoints included RLM, mean aortic gradient, and clinical events at 30 days and 1 year.Results: At 30 days, the frequency of HALT was 31 of 179 (17.3%) for TAVR and 23 of 139 (16.5%) for surgery; the frequency of RLM was 23 of 157 (14.6%) for TAVR and 19 of 133 (14.3%) for surgery. At 1 year, the frequency of HALT was 47 of 152 (30.9%) for TAVR and 33 of 116 (28.4%) for surgery; the frequency of RLM was 45 of 145 (31.0%) for TAVR and 30 of 111 (27.0%) for surgery. Aortic valve hemodynamic status was not influenced by the presence or severity of HALT or RLM at either time point. The rates of HALT and RLM were similar after the implantation of supra-annular, self-expanding transcatheter, or surgical bioprostheses.Conclusions: The presence of computed tomographic imaging abnormalities of aortic bioprostheses were frequent but dynamic in the first year after self-expanding transcatheter and surgical aortic valve replacement, but these findings did not correlate with aortic valve hemodynamic status after aortic valve replacement in patients at low risk for surgery. (Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients; NCT02701283). [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
24. Core Competencies in Cardiac CT for Imaging Structural Heart Disease Interventions: An Expert Consensus Statement.
- Author
-
Leipsic, Jonathon, Nørgaard, Bjarne L., Khalique, Omar, Cavalcante, João L., Wang, Dee Dee, Jilaihawi, Hasan, Delgado, Victoria, Bax, Jeroen J., and Blanke, Phlipp
- Published
- 2019
- Full Text
- View/download PDF
25. The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 Registry.
- Author
-
Hahn, Rebecca T., Pibarot, Philippe, Leipsic, Jonathon, Blanke, Philipp, Douglas, Pamela S., Weissman, Neil J., Kapadia, Samir, Thourani, Vinod H., Herrmann, Howard C., Nazif, Tamim, McAndrew, Thomas, Webb, John G., Leon, Martin B., and Kodali, Susheel
- Abstract
Objectives The purpose of this study was to understand the effects of balloon post-dilatation on outcomes following transcatheter aortic valve replacement with the SAPIEN 3 valve. Background Hemodynamics and outcomes with balloon post-dilatation for the SAPIEN 3 valve have not been previously reported. Methods The effects of balloon post-dilatation (BPD) in 1,661 intermediate (S3i cohort) and high surgical risk (S3HR cohort) patients with aortic stenosis enrolled in the PARTNER (Placement of Aortic Transcatheter Valves) 2, SAPIEN 3 observational study on outcomes, as well as procedural complications, were assessed. Results 208 of 1,661 patients (12.5%) had BPD during the initial transcatheter aortic valve replacement. Baseline characteristics were similar except BPD had higher STS score (p < 0.001), significantly less % oversizing (p = 0.004), significantly more ≥moderate left ventricular outflow tract calcification (p = 0.005), and severe annular calcification (p = 0.006). BPD patients had no increase in permanent pacemaker, annular rupture, or valve embolization. Following transcatheter aortic valve replacement, BPD patients had significantly larger aortic valve area (1.72 ± 0.41 cm 2 vs. 1.66 ± 0.37 cm 2 ; p = 0.04) with no significant difference in prosthesis–patient mismatch (p = 0.08) or transvalvular aortic regurgitation (p = 0.65), but significantly more paravalvular regurgitation (p < 0.01). There was no significant difference in 30-day or 1-year outcomes of all-cause death (p = 0.65 to 0.76) or stroke (p = 0.28 to 0.72). However, at 1 year, there was a significantly higher incidence of minor stroke in BPD patients (p = 0.02). Adjusting for baseline differences, including calcium burden, minor strokes were no longer significantly different between the BPD and NoBPD groups (p = 0.21). Conclusions BPD is performed more frequently in patients with lower % oversizing and greater calcium burden. BPD is not associated with procedural complications or an increase in 1-year adverse events of death, rehospitalization, or stroke. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
26. ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 Appropriate use criteria for the treatment of patients with severe aortic stenosis.
- Author
-
Bonow, Robert O., Brown, Alan S., Gillam, Linda D., Kapadia, Samir R., Kavinsky, Clifford J., Lindman, Brian R., Mack, Michael J., Thourani, Vinod H., Beaver, Thomas M., Bradley, Steven M., Carabello, Blase A., Desai, Milind Y., George, Isaac, Green, Philip, Holmes Jr, David R., Johnston, Douglas, Leipsic, Jonathon, Mick, Stephanie L., Passeri, Jonathan J., and Piana, Robert N.
- Subjects
AORTIC stenosis ,AORTIC stenosis treatment ,THORACIC surgery ,ECHOCARDIOGRAPHY ,PATIENTS - Abstract
The American College of Cardiology collaborated with the American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Valve Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons to develop and evaluate Appropriate Use Criteria (AUC) for the treatment of patients with severe aortic stenosis (AS). This is the first AUC to address the topic of AS and its treatment options, including surgical aortic valve replacement and transcatheter aortic valve replacement. A number of common patient scenarios experienced in daily practice were developed along with assumptions and definitions for those scenarios, which were all created using guidelines, clinical trial data and expert opinion in the field of AS. The '2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines' [1] and its 2017 focused update paper [2] were used as the primary guiding references in developing these indications. The Writing Group identified 95 clinical scenarios based on patient symptoms and clinical presentation, and up to 6 potential treatment options for those patients. A separate, independent Rating Panel was asked to score each indication from 1 to 9, with 1-3 categorized as 'Rarely Appropriate', 4-6 as 'May Be Appropriate' and 7-9 as 'Appropriate'. After considering factors such as symptom status, left ventricular function, surgical risk, and the presence of concomitant coronary or other valve disease, the Rating Panel determined that either surgical aortic valve replacement or transcatheter aortic valve replacement is appropriate in most patients with symptomatic AS at intermediate or high surgical risk; however, situations commonly arise in clinical practice in which the indications for surgical aortic valve replacement or transcatheter aortic valve replacement are less clear, including situations in which one form of valve replacement would appear reasonable when the other is less so, as do other circumstances in which neither intervention is the suitable treatment option. The purpose of this AUC is to provide guidance to clinicians in the care of patients with severe AS by identifying the reasonable treatment and intervention options available based on the myriad clinical scenarios with which patients present. This AUC document also serves as an educational and quality improvement tool to identify patterns of care and reduce the number of rarely appropriate interventions in clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
27. Computed Tomography–Based Oversizing Degrees and Incidence of Paravalvular Regurgitation of a New Generation Transcatheter Heart Valve.
- Author
-
Blanke, Philipp, Pibarot, Philippe, Hahn, Rebecca, Weissman, Neil, Kodali, Susheel, Thourani, Vinod, Parvataneni, Rupa, Dvir, Danny, Naoum, Christopher, Nørgaard, Bjarne L., Douglas, Pamela, Jaber, Wael, Khalique, Omar K., Jilaihawi, Hasan, Mack, Michael, Smith, Craig, Leon, Martin, Webb, John, and Leipsic, Jonathon
- Abstract
Objectives The aim of the study was to investigate the influence of the extent of computed tomography (CT)–based area and perimeter oversizing on the incidence and severity of paravalvular aortic regurgitation (PAR) for the Edwards SAPIEN 3 (Edwards Lifesciences, Irvine, California) device, using CT data and echocardiographic outcome data of the PARTNER II (Placement of AoRTic TraNscathetER Valves Trial II) SAPIEN 3 intermediate-risk cohort. Background Transcatheter heart valve (THV) sizing algorithms are device specific, requiring refinements for new valve designs. Methods A total of 835 intermediate-risk patients with severe, symptomatic aortic stenosis enrolled in a multicenter, nonrandomized registry at 57 sites in the United States and Canada with available systolic CT data and echocardiographic follow-up were included in this analysis. THV size selection was primarily CT guided based on annular area. Area-based and perimeter-based oversizing was calculated using systolic annular CT dimensions and nominal dimensions of the implanted THV size. PAR was assessed at 30 days according to a 5-class scheme. Results Mean oversizing by area was 7.7 ± 9.4% and mean oversizing by perimeter was 1.7 ± 4.4%. An inverse proportional relationship between degree of oversizing and frequency and severity of PAR was observed for both area and perimeter oversizing. Perimeter and area oversizing confer similar predictive capacity in regard to the occurrence of PAR after THV implantation (area under the curve: 0.78 [95% confidence interval: 0.70 to 0.85] vs. area under the curve: 0.78 [95% confidence interval: 0.72 to 0.85]; p < 0.0001). No aortic root ruptures were observed. Conclusions For the SAPIEN 3 THV, the frequency and extent of PAR is inversely related to the degree of oversizing with acceptable rates of PAR being achieved at lower degrees of oversizing. Perimeter and area oversizing confer similar predictive capacity in regard to the occurrence of PAR after implantation of the SAPIEN 3 THV. Therefore, the SAPIEN 3 THV may offer the opportunity to reduce the risk of annular rupture associated with more significant degrees of oversizing in borderline annular anatomy. (The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves [PARTNER II]; NCT01314313 ) [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
28. Trials Testing the Value of Imaging Use in Valve Disease and in Transcatheter Valvular Interventions.
- Author
-
Leipsic, Jonathon, Bax, Jeroen J., Webb, John G., Martin, Randolph, and Blanke, Philipp
- Abstract
The role of imaging in the diagnosis of valvular heart disease is well established through years of investigation and validation. However, the role of imaging in guiding the treatment decision-making for valvular heart disease is less well established, and there is a striking paucity of randomized trial data to help inform these decisions. Given this relative absence of randomized trial data, the present article highlights some of the most important knowledge gaps and defines meaningful opportunities for the field to help advance the care of patients with valvular heart disease in a cost-effective fashion. (The PARTNER 3-Trial: The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis [P3]; NCT02675114 ; Medtronic Transcatheter Aortic Valve Replacement in Low Risk Patients; NCT02701283 ) [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
29. Computed tomography assessment for transcatheter aortic valve in valve implantation: The vancouver approach to predict anatomical risk for coronary obstruction and other considerations.
- Author
-
Blanke, Philipp, Soon, Jeanette, Dvir, Danny, Park, Jong K., Naoum, Christopher, Kueh, Shaw-Hua, Wood, David A., Norgaard, Bjarne L., Selvakumar, Kapilan, Ye, Jian, Cheung, Anson, Webb, John G., and Leipsic, Jonathon
- Abstract
Valve-in-valve implantation of a transcatheter heart valve into a failed bioprosthetic heart valve has emerged as a treatment alternative to repeat conventional surgery. This requires careful pre-procedural assessment using non-invasive imaging to identify patients at risk for procedure related adverse events, such as ostial coronary occlusion. Herein we report how to comprehensively assess aortic root anatomy using computed tomography prior to transcatheter valve implantation for failed bioprosthetic aortic valves. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
30. Self-expanding Portico Valve Versus Balloon-expandable SAPIEN XT Valve in Patients With Small Aortic Annuli: Comparison of Hemodynamic Performance.
- Author
-
Del Trigo, María, Dahou, Abdellaziz, Webb, John G., Dvir, Danny, Puri, Rishi, Abdul-Jawad Altisent, Omar, Campelo-Parada, Francisco, Thompson, Chris, Leipsic, Jonathon, Stub, Dion, DeLarochellière, Robert, Paradis, Jean-Michel, Dumont, Eric, Doyle, Daniel, Mohammadi, Siamak, Pasian, Sergio, Côté, Melanie, Pibarot, Philippe, and Rodés-Cabau, Josep
- Abstract
Copyright of Revista Española de Cardiología (18855857) is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2016
- Full Text
- View/download PDF
31. Bicuspid Aortic Valve Stenosis: Favorable Early Outcomes With a Next-Generation Transcatheter Heart Valve in a Multicenter Study.
- Author
-
Perlman, Gidon Y., Blanke, Philipp, Dvir, Danny, Pache, Gregor, Modine, Thomas, Barbanti, Marco, Holy, Erik W., Treede, Hendrik, Ruile, Philipp, Neumann, Franz-Josef, Gandolfo, Caterina, Saia, Francesco, Tamburino, Corrado, Mak, George, Thompson, Christopher, Wood, David, Leipsic, Jonathon, and Webb, John G.
- Abstract
Objectives This study evaluated the results of transcatheter aortic valve replacement (TAVR) in bicuspid aortic stenosis (AS) using a new-generation TAVR device. Background A bicuspid AS is often considered a relative contraindication to TAVR. Although initial reports have demonstrated feasibility using early-generation devices, outcomes have not matched those seen with tricuspid AS. Paravalvular aortic regurgitation (AR) has been particularly problematic. Methods We collected baseline characteristics, procedural data, and 30-day clinical follow-up findings from 8 centers in Europe and Canada that had performed TAVR in bicuspid AS using the SAPIEN 3 valve. Results 51 patients underwent TAVR using the SAPIEN 3 valve. Patient mean age was 76.2 ± 9.3 years and the Society of Thoracic Surgeons predicted risk of mortality scores were 5.2 ± 3.7%. Bicuspid valve types were: type 0, 11.8%; type 1, 82.3%; and type 2, 1.9%. There were no cases of valve embolization or need for a second valve. Post-dilation was performed in 7.8%. The mean aortic gradient decreased from 49.4 ± 16.0 mm Hg to 11.2 ± 4.7 mm Hg. Post-implantation AR was none/trivial in 63% and mild in 37%. There were no cases of moderate or severe AR. At 30-day follow-up, there were 2 deaths (3.9%), 2 major vascular complications, and 12 patients (23.5%) required pacemaker implantation. Conclusions TAVR in bicuspid AS using a new-generation device was feasible and effective with favorable valve performance and no cases of moderate or severe AR. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
32. Clinical Outcomes and Imaging Findings in Women Undergoing TAVR.
- Author
-
Naoum, Christopher, Blanke, Philipp, Dvir, Danny, Pibarot, Philippe, Humphries, Karin, Webb, John, and Leipsic, Jonathon
- Abstract
Transcatheter aortic valve replacement (TAVR) has become the standard of care for patients with hemodynamically severe aortic stenosis who are symptomatic but deemed too high risk for surgery. Recent reports suggest that sex differences exist in outcomes following TAVR and in the diagnostic imaging evaluation of patients being considered for TAVR. In this review, the authors explore the differences between men and women in baseline characteristics and outcomes following TAVR, as well as sex differences in the imaging findings of severe aortic stenosis (AS) including the diagnostic challenges in the hemodynamic assessment of severe AS in elderly women, differences in aortic valvular calcification and in the associated myocardial response to severe AS. Additionally, sex differences in imaging findings as they relate to post-TAVR complications including coronary obstruction, annular rupture and prosthesis–patient mismatch are also discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
33. Regional Systems of Care to Optimize Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
- Author
-
Stub, Dion, Lauck, Sandra, Lee, May, Gao, Min, Humphries, Karin, Chan, Albert, Cheung, Anson, Cook, Richard, Della Siega, Anthony, Leipsic, Jonathon, Charania, Jay, Dvir, Danny, Latham, Tim, Polderman, Jopie, Robinson, Simon, Wong, Daniel, Thompson, Christopher R., Wood, David, Ye, Jian, and Webb, John
- Abstract
Objectives This study sought to describe the development of a multicenter, transcatheter aortic valve replacement program and regional systems of care intended to optimize coordinated, efficient, and appropriate delivery of this new therapy. Background Transcatheter aortic valve replacement (TAVR) has become an accepted treatment option for patients with severe aortic stenosis who are at high surgical risk. Regional systems of care have led to improvements in outcomes for patients undergoing intervention for myocardial infarction, cardiac arrest, and stroke. We implemented a regional system of care for patients undergoing TAVR in British Columbia, Canada. Methods We describe a prospective observational cohort of 583 patients who underwent TAVR in British Columbia between 2012 and 2014. Regionalization of TAVR care in British Columbia refers to a centrally coordinated, funded, and evaluated program led by a medical director and a multidisciplinary advisory group that oversees planning, access to care, and quality of outcomes at the 4 provincial sites. Risk-stratified case selection for transfemoral TAVR is performed by heart teams at each site on the basis of consensus provincial indications. Referrals for lower volume and more complicated TAVR, including nontransfemoral access and valve-in-valve procedures, are concentrated at a single site. In-hospital and 30-day outcomes are reported. Results The median age was 83 years (interquartile range [IQR]: 78 to 87 years) and median STS score was 6% (IQR: 4% to 8%). Transfemoral access was performed in 499 (85.6%) cases and nontransfemoral in 84 (14.4%). Transcatheter valve-in-valve procedures in for failed bioprosthetic valves were performed in 43 patients (7.4%). A balloon-expandable valve was inserted in 386 (66.2%) and a self-expanding valve in 189 (32.4%). All-cause 30-day mortality was 3.5%. All-cause in-hospital mortality and disabling stroke occurred in 3.1% and 1.9%, respectively. Median length of stay was 3 days (IQR: 3 to 6 days), with 92.8% of patients discharged directly home. Conclusions This experience demonstrates the potential benefits of a regional system of care for TAVR. Excellent outcomes were demonstrated: most patients had short in-hospital stays and were discharged directly home. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
34. Using advanced analytics to advance our understanding of aortic stenosis and risk.
- Author
-
Zekry, Sagit Ben and Leipsic, Jonathon
- Subjects
BLOOD vessels ,HEART valve prosthesis implantation ,AORTIC stenosis ,CALCINOSIS ,COMPUTED tomography - Published
- 2021
- Full Text
- View/download PDF
35. Open issues in transcatheter aortic valve implantation. Part 1: patient selection and treatment strategy for transcatheter aortic valve implantation.
- Author
-
Bax, Jeroen J., Delgado, Victoria, Bapat, Vinayak, Baumgartner, Helmut, Collet, Jean P., Erbel, Raimund, Hamm, Christian, Kappetein, Arie P., Leipsic, Jonathon, Leon, Martin B., MacCarthy, Philip, Piazza, Nicolo, Pibarot, Philippe, Roberts, William C., Rodés-Cabau, Josep, Serruys, Patrick W., Thomas, Martyn, Vahanian, Alec, Webb, John, and Zamorano, Jose Luis
- Abstract
An exponential increase in the use of transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis has been witnessed over the recent years. The current article reviews different areas of uncertainty related to patient selection. The use and limitations of risk scores are addressed, followed by an extensive discussion on the value of three-dimensional imaging for prosthesis sizing and the assessment of complex valve anatomy such as degenerated bicuspid valves. The uncertainty about valvular stenosis severity in patients with a mismatch between the transvalvular gradient and the aortic valve area, and how integrated use of echocardiography and computed tomographic imaging may help, is also addressed. Finally, patients referred for TAVI may have concomitant mitral regurgitation and/or coronary artery disease and the management of these patients is discussed. [ABSTRACT FROM PUBLISHER]
- Published
- 2014
- Full Text
- View/download PDF
36. Management of Vascular Access in Transcatheter Aortic Valve Replacement: Part 2: Vascular Complications.
- Author
-
Toggweiler, Stefan, Leipsic, Jonathon, Binder, Ronald K., Freeman, Melanie, Barbanti, Marco, Heijmen, Robin H., Wood, David A., and Webb, John G.
- Abstract
The interventional cardiologist must be able to recognize and manage potential vascular complications. Iliofemoral complications are the most frequent vascular complications in transfemoral transcatheter aortic valve implantation. Small vessel dimensions, moderate or severe calcification, and center experience are the major predictors. The traditional treatment for injured arteries has been surgical reconstruction, but endovascular techniques may allow for less invasive but effective management of arterial injuries. Dissection may be treated with prolonged balloon inflation or deployment of a self-expanding or balloon-expandable stent or a surgical graft. Iliofemoral rupture is a serious complication that may lead to retroperitoneal bleeding that can be unrecognized. Rapid insertion of a dilator or sheath or an occlusive balloon is used to achieve hemostasis. Prolonged balloon inflation or implantation of a covered stent or surgical repair should then be considered. Treatment options for failed percutaneous closure include prolonged manual compression, balloon angioplasty, stent implantation, and surgery. Aortic complications are rare, but serious complications are associated with a high mortality rate, even if emergent surgery is performed. There are specific vascular complications associated with alternative access routes such as transapical and transaxillary and direct aortic access. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
37. Management of Vascular Access in Transcatheter Aortic Valve Replacement: Part 1: Basic Anatomy, Imaging, Sheaths, Wires, and Access Routes.
- Author
-
Toggweiler, Stefan, Leipsic, Jonathon, Binder, Ronald K., Freeman, Melanie, Barbanti, Marco, Heijmen, Robin H., Wood, David A., and Webb, John G.
- Abstract
Transcatheter aortic valve implantation (TAVI) has emerged as a new therapy for patients with severe aortic stenosis who are inoperable or at very high risk of open heart surgery. Vascular complications are a potential limitation of TAVI and have been associated with bleeding, transfusions, and mortality. Transfemoral TAVI can be considered the least invasive approach and is therefore the most widely used access for TAVI. With the current 18-F to 24-F sheaths, the majority of patients can be treated via the transfemoral route. Initially, open surgical access was routinely used to introduce the large sheaths and catheters. Subsequently, percutaneous techniques have emerged as the new standard, resulting in a less invasive, fully percutaneous procedure. Stiff wires allow insertion of the sheath and delivery of the device without causing trauma to the artery. Given the high burden of vascular disease in TAVI candidates, increasing the effectiveness of pre-procedural screening is key. This often begins with conventional angiography, but computed tomography allows visualization of the artery in 3 dimensions, thereby overcoming some of the limitations of conventional angiography. Approximately one third of patients do not have adequate anatomy to allow safe transfemoral access. In such patients, alternative access routes such as the transapical, transaxillary, or direct aortic access are preferred. These alternative routes all have specific advantages and disadvantages. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
38. Multidetector CT predictors of prosthesis–patient mismatch in transcatheter aortic valve replacement.
- Author
-
Freeman, Melanie, Webb, John G., Willson, Alexander B., Wheeler, Miriam, Blanke, Philipp, Moss, Robert R., Thompson, Christopher R., Munt, Brad, Norgaard, Bjarne L., Yang, Tae-Hyun, Min, James K., Poulsen, Steen, Hansson, Nicolaj C., Binder, Ronald K., Toggweiler, Stefan, Hague, Cameron, Wood, David A., Pibarot, Philippe, and Leipsic, Jonathon
- Abstract
Abstract: Background: Prosthesis–patient mismatch (PPM) is a predictor of mortality after aortic valve replacement (AVR). Objective: We examined whether accurate 3-dimensional annular sizing with multidetector CT (MDCT) is predictive of PPM after transcatheter AVR (TAVR). Methods: One hundred twenty-eight patients underwent MDCT then TAVR. Moderate PPM was defined as an indexed effective orifice area ≤0.85 cm
2 /m2 and severe ≤0.65 cm2 /m2 . MDCT annular measurements (area, short and long axis) were compared with the size of the selected transcatheter heart valve (THV) to obtain (1) the difference between prosthesis size and CT-measured mean annular diameter and (2) the percentage of undersizing or oversizing (calculated as 100 × [MDCT annular area – THV nominal area]/THV nominal area). In addition, the MDCT annular area was indexed to body surface area. These measures were evaluated as potential PPM predictors. Results: We found that 42.2% of patients had moderate PPM and 9.4% had severe PPM. Procedural characteristics and in-hospital outcomes were similar between patients with or without PPM. THV undersizing of the mean aortic annulus diameter was not predictive of PPM (odds ratio [OR], 0.84; 95% CI, 0.65–1.07; P = .16; area under the receiver-operating characteristic curve [AUC], 0.58). THV undersizing of annular area was not predictive of PPM (OR, 0.96; 95% CI, 0.80–1.16; P = .69; AUC, 0.52). Indexed MDCT annular area was, however, predictive of PPM (OR, 0.24; 95% CI, 0.10–0.59; P < .001; AUC, 0.66). Conclusions: PPM is frequent after TAVR. Appropriate annular oversizing does not reduce the rate or severity of PPM. Patient annulus size mismatch, identified by indexed MDCT annular area, is a significant predictor of PPM. [Copyright &y& Elsevier]- Published
- 2013
- Full Text
- View/download PDF
39. Transcatheter Valve-In-Valve Implantation for Failed Balloon-Expandable Transcatheter Aortic Valves.
- Author
-
Toggweiler, Stefan, Wood, David A., Rodés-Cabau, Josep, Kapadia, Samir, Willson, Alexander B., Ye, Jian, Cheung, Anson, Leipsic, Jonathon, Binder, Ronald K., Gurvitch, Ronen, Freeman, Melanie, Thompson, Christopher R., Svensson, Lars G., Dumont, Eric, Tuzcu, E. Murat, and Webb, John G.
- Subjects
CARDIAC surgery patients ,AORTIC valve insufficiency ,MORTALITY ,INTRA-aortic balloon counterpulsation ,MEDICAL statistics ,HOSPITAL care - Abstract
Objectives: This study sought to evaluate outcomes after implantation of a second transcatheter heart valve (THV-in-THV) for acute THV failure. Background: Aortic regurgitation after transcatheter aortic valve replacement (TAVR) may be valvular due to prosthetic leaflet dysfunction or paravalvular due to poor annular sealing. Methods: Patients undergoing aortic balloon-expandable TAVR at 3 centers were prospectively evaluated at baseline, intraprocedurally, at hospital discharge, and annually. Results: Of 760 patients undergoing TAVR, 21 (2.8%) received a THV-in-THV implant due to acute, severe regurgitation. Aortic regurgitation was paravalvular in 18 patients and transvalvular in the remaining 3 patients. THV-in-THV implantation was technically successful in 19 patients (90%) and unsuccessful in 2 patients (10%), who subsequently underwent open heart surgery. Mortality at 30 days and 1 year was 14.3% and 24%, respectively. After successful THV-in-THV, mean aortic valve gradient fell from 37 ± 12 mm Hg to 13 ± 5 mm Hg (p < 0.01); aortic valve area increased from 0.64 ± 0.14 cm
2 to 1.55 ± 0.27 cm2 (p < 0.01); and paravalvular aortic regurgitation was none in 4 patients, mild in 13 patients, and moderate in 2 patients. At 1-year follow-up, 1 patient had moderate and the others had mild or no paravalvular leaks. The mean transvalvular gradient was 15 ± 4 mm Hg, which was higher than in patients undergoing conventional TAVR (11 ± 4 mm Hg, p = 0.02). Conclusions: THV-in-THV implantation is feasible and results in satisfactory short- and mid-term outcomes. [ABSTRACT FROM AUTHOR]- Published
- 2012
- Full Text
- View/download PDF
40. Structural Integrity of Balloon-Expandable Stents After Transcatheter Aortic Valve Replacement: Assessment by Multidetector Computed Tomography.
- Author
-
Willson, Alexander B., Webb, John G., Gurvitch, Ronen, Wood, David A., Toggweiler, Stefan, Binder, Ronald, Freeman, Melanie, Madden, Mark, Hague, Cameron, and Leipsic, Jonathon
- Subjects
AORTIC valve surgery ,TOMOGRAPHY ,HEALTH risk assessment ,CARDIAC catheterization ,ECHOCARDIOGRAPHY - Abstract
Objectives: This study sought to evaluate the structural integrity of balloon-expandable stents used in transcatheter aortic valve replacement. Background: Underexpansion, deformation, or fracture of stent frames may affect transcatheter heart valve (THV) function and durability. Methods: Patients >1 year after transcatheter aortic valve replacement underwent multidetector computed tomography. Geometry of the stent frame was assessed for circularity; eccentricity; minimum and maximum external diameter; and expansion at the inflow, mid-stent, and outflow levels, as well as for stent fracture. THV noncircularity was defined as stent eccentricity >10% (1 – minimum diameter/maximum diameter) and THV underexpansion when expansion <90% (multidetector computed tomography derived external valve area/nominal external valve area). Echocardiography was performed after implantation and annually. Results: Fifty patients underwent multidetector computed tomography at an average of 2.5 ± 0.9 years after transcatheter aortic valve replacement (35 Sapien, 8 Sapien XT, and 7 Cribier-Edwards valves [all Edwards Lifesciences, Irvine, California). The mean external diameter for the 23- and 26-mm valves was 23.3 ± 0.9 mm and 25.9 ± 0.9 mm, respectively. Circularity was present in 96% (48 of 50) and median eccentricity was 2.0% (interquartile range: 1.2% to 3.0%). Mean THV expansion was 104.1 ± 7.4%, which increased from stent inflow to outflow (100.8 ± 7.6% vs. 108.1 ± 6.9%, p < 0.001). Stent fracture was not observed. Underexpanded valves (8% [4 of 50]) and noncircular valves (4% [2 of 50]) demonstrated stable hemodynamic function on annual echocardiography. Conclusions: Balloon-expandable aortic valves have excellent rates of circularity with low eccentricity and maintain full expansion without stent fracture at an average 2.5 years after implantation. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
41. A Practical Guide to Multimodality Imaging of Transcatheter Aortic Valve Replacement.
- Author
-
Bloomfield, Gerald S., Gillam, Linda D., Hahn, Rebecca T., Kapadia, Samir, Leipsic, Jonathon, Lerakis, Stamatios, Tuzcu, Murat, and Douglas, Pamela S.
- Subjects
MAGNETIC resonance ,AORTIC stenosis ,TOMOGRAPHY ,ECHOCARDIOGRAPHY ,LEFT heart ventricle ,CARDIAC surgery ,CARDIAC imaging - Abstract
The advent of transcatheter aortic valve replacement (TAVR) is one of the most widely anticipated advances in the care of patients with severe aortic stenosis. This procedure is unique in many ways, one of which is the need for a multimodality imaging team-based approach throughout the continuum of the care of TAVR patients. Pre-procedural planning, intra-procedural implantation optimization, and long-term follow-up of patients undergoing TAVR require the expert use of various imaging modalities, each of which has its own strengths and limitations. Divided into 3 sections (pre-procedural, intraprocedural, and long-term follow-up), this review offers a single source for expert opinion and evidence-based guidance on how to incorporate the various modalities at each step in the care of a TAVR patient. Although much has been learned in the short span of time since TAVR was introduced, recommendations are offered for clinically relevant research that will lead to refinement of best practice strategies for incorporating multimodality imaging into TAVR patient care. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
42. Aortic Annulus Diameter Determination by Multidetector Computed Tomography: Reproducibility, Applicability, and Implications for Transcatheter Aortic Valve Implantation.
- Author
-
Gurvitch, Ronen, Webb, John G., Yuan, Ren, Johnson, Mark, Hague, Cameron, Willson, Alexander B., Toggweiler, Stefan, Wood, David A., Ye, Jian, Moss, Robert, Thompson, Christopher R., Achenbach, Stephan, Min, James K., LaBounty, Troy M., Cury, Ricardo, and Leipsic, Jonathon
- Subjects
AORTIC valve surgery ,CARDIAC catheterization ,TRANSESOPHAGEAL echocardiography ,CARDIOGRAPHIC tomography ,STATISTICAL correlation ,CONFIDENCE intervals - Abstract
Objectives: This study sought to determine the most reproducible multidetector computed tomography (MDCT) measurements of the aortic annulus and to determine methods to improve the applicability of these measurements for transcatheter aortic valve implantation. Background: The reproducibility and applicability of MDCT annular measurements to guide transcatheter aortic valve implantation remain unclear. Methods: Annular measurements were performed in 50 patients planed for transcatheter aortic valve implantation in multiple planes: basal ring (short- and long-axis, mean diameter, area-derived diameter), coronal, sagittal, and 3-chamber projections. A theoretical model was developed taking into account the differences between the most reproducible MDCT measurements and transesophageal echocardiography to guide valve size choice. Results: The most reproducible measurements were the area-derived diameter and basal ring average diameter (inter-reader intraclass correlation coefficient: 0.87 [95% confidence interval: 0.81 to 0.92] and 0.80 [95% confidence interval: 0.70 to 0.87]; respectively; intrareader >0.90 for all readers). These were generally larger than transesophageal echocardiography diameters (mean difference of 1.5 ± 1.6 mm and 1.1 ± 1.7 mm, respectively). When a strategy of valve-sizing is undertaken using these CT measurements using an echocardiographic sizing scale, a different THV size would be selected in 44% and 40% of cases, respectively. When adjusting the sizing cutoffs to account for the differences in observed diameters, this was reduced to 10% to 12% (p < 0.01 for both, respectively). Conclusions: The most reproducible MDCT measurements of the annulus are the area-derived diameter and basal ring average diameter, with derived values generally larger than those obtained with echocardiography. If MDCT is used for valve sizing, a strategy incorporating these differences may be important. MDCT using these easily derived measurements may be ideally suited to sizing transcatheter aortic valves as they account for the eccentricity of the aortic annulus, are reproducible, and are noninvasive. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
43. Multidetector Computed Tomography in Transcatheter Aortic Valve Implantation.
- Author
-
Leipsic, Jonathon, Gurvitch, Ronen, LaBounty, Troy M., Min, James K., Wood, David, Johnson, Mark, Ajlan, Amr M., Wijesinghe, Namal, and Webb, John G.
- Subjects
AORTIC stenosis ,AORTIC valve transplantation ,MEDICAL screening ,TOMOGRAPHY ,ANGIOGRAPHY ,ELECTROCARDIOGRAPHY - Abstract
Aortic stenosis is a common disorder. Aortic valve replacement is indicated in symptomatic patients with severe aortic stenosis, as the prognosis of untreated patients is poor. Nevertheless, many patients pose a prohibitively high surgical risk and are not candidates for surgical valve replacement. Transcatheter aortic valve implantation (TAVI) is a novel method to treat selected high-risk patients with aortic stenosis. Patient screening and anatomic measurements of the aortic root are of great importance to ensure procedural success and appropriate patient selection. Multidetector computed tomography (CT) is playing an increasingly important role in patient screening protocols before TAVI, provides detailed anatomic assessment of the aortic root and valve annulus, assesses the suitability of iliofemoral access, and determines appropriate coaxial angles to optimize the valve implantation procedure. Additionally, CT is providing a greater understanding of medium-term valve durability and integrity. This review outlines an evolving role for CT angiography in support of a TAVI program and describe step by step how CT can be used to enhance the procedure and provide a practical guide for the utilization of CT angiography in support of a transcatheter aortic valve program. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
44. Multislice Computed Tomography for Prediction of Optimal Angiographic Deployment Projections During Transcatheter Aortic Valve Implantation.
- Author
-
Gurvitch, Ronen, Wood, David A., Leipsic, Jonathon, Tay, Edgar, Johnson, Mark, Ye, Jian, Nietlispach, Fabian, Wijesinghe, Namal, Cheung, Anson, and Webb, John G.
- Subjects
AORTIC stenosis ,TOMOGRAPHY ,ARTERIAL catheters ,ARTIFICIAL implants ,AORTIC valve surgery ,ANGIOGRAPHY - Abstract
Objectives: This study assessed whether multislice computed tomography (MSCT) could predict optimal angiographic projections for visualizing the plane of the native valve and facilitate accurate positioning during transcatheter aortic valve implantation (TAVI). Background: Accurate device positioning during TAVI depends on valve deployment in angiographic projections perpendicular to the native valve plane, but these may be difficult to determine. Methods: Twenty patients underwent MSCT before TAVI. Using a novel technique, multiple angiographic projections accurately representing the native valve plane in multiple axes were determined. The accuracy of all predicted projections was determined post-procedure using angiography according to new criteria, based on valve perpendicularity and the degree of strut overlap (defined as excellent, satisfactory, or poor). The accuracy of valve deployment using MSCT was compared with the results of 20 consecutive patients undergoing TAVI without such MSCT angle prediction. Results: Correct final deployment projections were more frequent in the MSCT-guided compared with non–MSCT-guided group: excellent or satisfactory projections (90% vs. 65%, p = 0.06). The MSCT angle prediction was accurate but dependent on optimal images (optimal images: 93% of predicted angles were excellent or satisfactory, suboptimal images: 73% of predicted angles were poor). A “line of perpendicularity” could be generated with optimal projections across the right-to-left anterior oblique plane by adding the correct cranial or caudal angulation. Conclusions: Pre-procedural MSCT can predict optimal angiographic deployment projections for implantation of transcatheter valves. An ideal deployment angle curve or “line of perpendicularity” can be generated. Understanding and applying these principles improves the accuracy of valve deployment and may improve outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
45. Management of Vascular Access in Transcatheter Aortic Valve Replacement Part 2: Vascular Complications
- Author
-
Toggweiler, Stefan, Leipsic, Jonathon, Binder, Ronald K., Freeman, Melanie, Barbanti, Marco, Heijmen, Robin H., Wood, David A., and Webb, John G.
- Subjects
complications ,aortic stenosis ,transcatheter aortic valve replacement ,transcatheter aortic valve implantation - Abstract
The interventional cardiologist must be able to recognize and manage potential vascular complications. Iliofemoral complications are the most frequent vascular complications in transfemoral transcatheter aortic valve implantation. Small vessel dimensions, moderate or severe calcification, and center experience are the major predictors. The traditional treatment for injured arteries has been surgical reconstruction, but endovascular techniques may allow for less invasive but effective management of arterial injuries. Dissection may be treated with prolonged balloon inflation or deployment of a self-expanding or balloon-expandable stent or a surgical graft. Iliofemoral rupture is a serious complication that may lead to retroperitoneal bleeding that can be unrecognized. Rapid insertion of a dilator or sheath or an occlusive balloon is used to achieve hemostasis. Prolonged balloon inflation or implantation of a covered stent or surgical repair should then be considered. Treatment options for failed percutaneous closure include prolonged manual compression, balloon angioplasty, stent implantation, and surgery. Aortic complications are rare, but serious complications are associated with a high mortality rate, even if emergent surgery is performed. There are specific vascular complications associated with alternative access routes such as transapical and transaxillary and direct aortic access.
- Full Text
- View/download PDF
46. Aortic Annulus Diameter Determination by Multidetector Computed Tomography Reproducibility, Applicability, and Implications for Transcatheter Aortic Valve Implantation
- Author
-
Gurvitch, Ronen, Webb, John G., Yuan, Ren, Johnson, Mark, Hague, Cameron, Willson, Alexander B., Toggweiler, Stefan, Wood, David A., Ye, Jian, Moss, Robert, Thompson, Christopher R., Achenbach, Stephan, Min, James K., LaBounty, Troy M., Cury, Ricardo, and Leipsic, Jonathon
- Subjects
aortic annulus ,cardiovascular system ,aortic stenosis ,computed tomography ,cardiovascular diseases ,transcatheter aortic valve implantation - Abstract
ObjectivesThis study sought to determine the most reproducible multidetector computed tomography (MDCT) measurements of the aortic annulus and to determine methods to improve the applicability of these measurements for transcatheter aortic valve implantation.BackgroundThe reproducibility and applicability of MDCT annular measurements to guide transcatheter aortic valve implantation remain unclear.MethodsAnnular measurements were performed in 50 patients planed for transcatheter aortic valve implantation in multiple planes: basal ring (short- and long-axis, mean diameter, area-derived diameter), coronal, sagittal, and 3-chamber projections. A theoretical model was developed taking into account the differences between the most reproducible MDCT measurements and transesophageal echocardiography to guide valve size choice.ResultsThe most reproducible measurements were the area-derived diameter and basal ring average diameter (inter-reader intraclass correlation coefficient: 0.87 [95% confidence interval: 0.81 to 0.92] and 0.80 [95% confidence interval: 0.70 to 0.87]; respectively; intrareader >0.90 for all readers). These were generally larger than transesophageal echocardiography diameters (mean difference of 1.5 ± 1.6 mm and 1.1 ± 1.7 mm, respectively). When a strategy of valve-sizing is undertaken using these CT measurements using an echocardiographic sizing scale, a different THV size would be selected in 44% and 40% of cases, respectively. When adjusting the sizing cutoffs to account for the differences in observed diameters, this was reduced to 10% to 12% (p < 0.01 for both, respectively).ConclusionsThe most reproducible MDCT measurements of the annulus are the area-derived diameter and basal ring average diameter, with derived values generally larger than those obtained with echocardiography. If MDCT is used for valve sizing, a strategy incorporating these differences may be important. MDCT using these easily derived measurements may be ideally suited to sizing transcatheter aortic valves as they account for the eccentricity of the aortic annulus, are reproducible, and are noninvasive.
- Full Text
- View/download PDF
47. Management of Vascular Access in Transcatheter Aortic Valve Replacement Part 1: Basic Anatomy, Imaging, Sheaths, Wires, and Access Routes
- Author
-
Toggweiler, Stefan, Leipsic, Jonathon, Binder, Ronald K., Freeman, Melanie, Barbanti, Marco, Heijmen, Robin H., Wood, David A., and Webb, John G.
- Subjects
vascular complications ,aortic stenosis ,transcatheter aortic valve replacement ,transcatheter aortic valve implantation - Abstract
Transcatheter aortic valve implantation (TAVI) has emerged as a new therapy for patients with severe aortic stenosis who are inoperable or at very high risk of open heart surgery. Vascular complications are a potential limitation of TAVI and have been associated with bleeding, transfusions, and mortality. Transfemoral TAVI can be considered the least invasive approach and is therefore the most widely used access for TAVI. With the current 18-F to 24-F sheaths, the majority of patients can be treated via the transfemoral route. Initially, open surgical access was routinely used to introduce the large sheaths and catheters. Subsequently, percutaneous techniques have emerged as the new standard, resulting in a less invasive, fully percutaneous procedure. Stiff wires allow insertion of the sheath and delivery of the device without causing trauma to the artery. Given the high burden of vascular disease in TAVI candidates, increasing the effectiveness of pre-procedural screening is key. This often begins with conventional angiography, but computed tomography allows visualization of the artery in 3 dimensions, thereby overcoming some of the limitations of conventional angiography. Approximately one third of patients do not have adequate anatomy to allow safe transfemoral access. In such patients, alternative access routes such as the transapical, transaxillary, or direct aortic access are preferred. These alternative routes all have specific advantages and disadvantages.
- Full Text
- View/download PDF
48. Outcome of Flow-Gradient Patterns of Aortic Stenosis After Aortic Valve Replacement: An Analysis of the PARTNER 2 Trial and Registry.
- Author
-
Salaun, Erwan, Clavel, Marie-Annick, Hahn, Rebecca T., Jaber, Wael A., Asch, Federico M., Rodriguez, Leonardo, Weissman, Neil J., Gertz, Zachary M., Herrmann, Howard C., Dahou, Abdellaziz, Annabi, Mohamed-Salah, Toubal, Oumhani, Bernier, Mathieu, Beaudoin, Jonathan, Leipsic, Jonathon, Blanke, Philipp, Ridard, Carine, Ong, Géraldine, Rodés-Cabau, Josep, and Webb, John G.
- Abstract
Supplemental Digital Content is available in the text. Background: Although aortic valve replacement is associated with a major benefit in high-gradient (HG) severe aortic stenosis (AS), the results in low-gradient (LG, mean gradient <40 mm Hg) AS are conflicting. LG severe AS may be subdivided in classical low-flow (left ventricular ejection fraction <50%) and LG (CLF-LG); paradoxical low-flow (left ventricular ejection fraction ≥50% but stroke volume index <35 mL/m
2 ) and LG; and normal-flow (left ventricular ejection fraction ≥50% and stroke volume index ≥35 mL/m2 ) and LG. The primary objective is to determine in the PARTNER 2 trial (The Placement of Aortic Transcatheter Valves) and registry the outcomes after aortic valve replacement of the 4 flow-gradient groups. Methods: A total of 3511 patients from the PARTNER 2 Cohort A randomized trial (n=1910) and SAPIEN 3 registry (n=1601) were included. The flow-gradient pattern was determined at baseline transthoracic echocardiography and classified as follows: (1) HG; (2) CLF-LG; (3) paradoxical low-flow-LG; and (4) normal-flow-LG. The primary end point for this analysis was the composite of (1) death; (2) rehospitalization for heart failure symptoms and valve prosthesis complication; or (3) stroke. Results: The distribution was HG, 2229 patients (63.5%); CLF-LG, 689 patients (19.6%); paradoxical low-flow-LG, 247 patients (7.0%); and normal-flow-LG, 346 patients (9.9%). The 2-year rate of primary end point was higher in CLF-LG (38.8%) versus HG: 31.8% (P =0.002) and normal-flow-LG: 32.1% (P =0.05) but was not statistically different from paradoxical low-flow-LG: 33.6% (P =0.18). There was no significant difference in the 2-year rates of clinical events between transcatheter aortic valve replacement versus surgical aortic valve replacement in the whole cohort and within each flow-gradient group. Conclusions: The LG AS pattern was highly prevalent (36.5%) in the PARTNER 2 trial and registry. CLF-LG was the most common pattern of LG AS and was associated with higher rates of death, rehospitalization, or stroke at 2 years compared with the HG group. Clinical outcomes were as good in the LG AS groups with preserved left ventricular ejection fraction compared with the HG group. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
49. ACR Appropriateness Criteria® Imaging for Transcatheter Aortic Valve Replacement.
- Author
-
Leipsic, Jonathon A., Blanke, Philipp, Hanley, Michael, Batlle, Juan C., Bolen, Michael A., Brown, Richard K.J., Desjardins, Benoit, Eberhardt, Robert T., Gornik, Heather L., Hurwitz, Lynne M., Maniar, Hersh, Patel, Himanshu J., Sheybani, Elizabeth F., Steigner, Michael L., Verma, Nupur, Abbara, Suhny, Rybicki, Frank J., Kirsch, Jacobo, Dill, Karin E., and Expert Panel on Cardiac Imaging and Vascular Imaging:
- Abstract
Aortic stenosis is a common valvular condition with increasing prevalence in aging populations. When severe and symptomatic, the downstream prognosis is poor without surgical or transcatheter aortic valve replacement. Transcatheter aortic valve replacement is now considered a viable alternative to surgical aortic valve replacement in patients considered high and intermediate risk for surgery. Pre-intervention imaging with echocardiography and CT are essential for procedure planning and device selection to help optimize clinical outcomes with MR angiography playing largely a complementary role. Modern 3-D cross-sectional imaging has consistently shown to help reduce procedural complications from vascular access injury to paravalvular regurgitation and coronary obstruction. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
50. Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves: PARTNER 3 Cardiac Computed Tomography Substudy.
- Author
-
Makkar, Raj R, Blanke, Philipp, Leipsic, Jonathon, Thourani, Vinod, Chakravarty, Tarun, Brown, David, Trento, Alfredo, Guyton, Robert, Babaliaros, Vasilis, Williams, Mathew, Jilaihawi, Hasan, Kodali, Susheel, George, Isaac, Lu, Michael, McCabe, James M, Friedman, John, Smalling, Richard, Wong, Shing Chiu, Yazdani, Shahram, and Bhatt, Deepak L
- Subjects
- *
THROMBOSIS , *RESEARCH , *RESEARCH methodology , *AORTIC stenosis , *SURGICAL complications , *EVALUATION research , *MEDICAL cooperation , *COMPARATIVE studies , *PROSTHETIC heart valves , *COMPUTED tomography - Abstract
Background: Subclinical leaflet thrombosis, characterized by hypoattenuated leaflet thickening (HALT) and reduced leaflet motion observed on 4-dimensional computed tomography (CT), may represent a form of bioprosthetic valve dysfunction.Objectives: The U.S. Food and Drug Administration mandated CT studies to understand the natural history of this finding, differences between transcatheter and surgical valves, and its association with valve hemodynamics and clinical outcomes.Methods: The PARTNER 3 (The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low-Risk Patients With Aortic Stenosis) CT substudy randomized 435 patients with low-surgical-risk aortic stenosis to undergo transcatheter aortic valve replacement (n = 221) or surgery (n = 214). Serial 4-dimensional CTs were performed at 30 days and 1 year and were analyzed independently by a core laboratory.Results: The incidence of HALT increased from 10% at 30 days to 24% at 1 year. Spontaneous resolution of 30-day HALT occurred in 54% of patients at 1 year, whereas new HALT appeared in 21% of patients at 1 year. HALT was more frequent in transcatheter versus surgical valves at 30 days (13% vs. 5%; p = 0.03), but not at 1 year (28% vs. 20%; p = 0.19). The presence of HALT did not significantly affect aortic valve mean gradients at 30 days or 1 year. Patients with HALT at both 30 days and 1 year, compared with those with no HALT at 30 days and 1 year, had significantly increased aortic valve gradients at 1 year (17.8 ± 2.2 mm Hg vs. 12.7. ± 0.3 mm Hg; p = 0.04).Conclusions: Subclinical leaflet thrombosis was more frequent in transcatheter compared with surgical valves at 30 days, but not at 1 year. The impact of HALT on thromboembolic complications and structural valve degeneration needs further assessment. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.